Project co-funded by the European Regional Development Fund (ERDF) and the Consejería de Economía, Ciencia y Agenda Digital of Govern of Extremadura

PISA, Italy, June 8, 2022 – Medical Microinstruments (MMI), a robotics company dedicated to improving clinical outcomes for patients undergoing microsurgery, today announced that it will participate in “THE MINIMALLY INVASIVE ROBOTIC SURGERY SYSTEMS project (TREMIRS), REFERENCE: CPI-2019-33-1-TRE-14, in the framework of the Line for the Promotion of Innovation from the Demand for the Public Purchase of Innovation (FID-CPI Line) of the Ministry of Science and Innovation and a total budget of 7,345,300.00 €, has been co-funded (80%) by the European Regional Development Fund through a grant given by the Regional Ministry of Economy, Industry and Tourism (5.876.240,00€) and co-funded (20%) by Consejería de Economía, Ciencia y Agenda Digital of Govern of Extremadura (1.469.060,00€).”

TREMIRS aims to improve the currently available surgical robotic systems for both laparoscopy and microsurgery to offer better solutions for patients, improved ergonomics for surgeons and greater performance for surgical teams to ultimately improve the quality of care. There are two aspects of this project: (1) The development of a robotic platform for laparoscopic surgery that addresses the limitations of current robotic laparoscopic surgery systems available on the market, and (2) the development of a teleoperated robotic platform for reconstructive microsurgery, consisting of robotic micro-instruments with high maneuverability and precision.

Together with Jesús Usón Minimally Invasive Surgery Centre (Spain), MMI will address the 2nd part of the project related to advancing a Robotic platform for microsurgery. The project will focus on specific improvements to the Symani® Surgical System, which received CE mark in November of 2019, and the development of additional NanoWrist® Instruments.

About MMI

Medical Microinstruments (MMI) was founded in 2015 near Pisa, Italy to enhance surgical performance through the development of a robotic system that enables surgeons to achieve better outcomes in microsurgery. The Symani Surgical System combines proprietary innovations including the world’s smallest wristed microinstruments as well as tremor-reducing and motionscaling technologies. Together, these powerful capabilities allow more surgeons to successfully perform microsurgery while expanding the field of supermicrosurgery. MMI is backed by international medtech investors including Andera Partners, Panakes Partners, Fountain Healthcare Partners and Sambatech.